INDIANAPOLIS , Jan. 15, 2021 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter and full-year 2020 financial results on Friday, January 29, 2021 . Lilly will also conduct a conference call on that day with the investment community and media to further detail the

INDIANAPOLIS , Jan. 4, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the 39 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 . David A. Ricks , Lilly 's chairman and chief executive officer, will participate in a virtual fireside chat at 8:20 a.m.

- Lilly expects to deliver strong financial and operational performance in 2021, highlighted by volume-based revenue growth, operating margin expansion, pipeline advancements and solid cash flow. - 2021 revenue is expected to be between $26.5 billion and $28.0 billion, driven by volume growth from

INDIANAPOLIS , Dec. 14, 2020 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) today announced a 15 percent increase in its quarterly dividend. The dividend for the first quarter of 2021 will be $0.85 per share on outstanding common stock.

INDIANAPOLIS , Dec. 8, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will announce its financial guidance for 2021 on Tuesday, December 15, 2020 . Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial

INDIANAPOLIS , Nov. 24, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Evercore ISI 3 rd Annual HealthCONx Conference on Tuesday, December 1, 2020 . Michael Mason , Lilly senior vice president and president of Lilly Diabetes and Connected Care, will participate in a

INDIANAPOLIS , Nov. 12, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE:LLY) will participate in the Wolfe Research Virtual Healthcare Conference on Wednesday, November 18, 2020 . Joshua Smiley , senior vice president and Lilly 's chief financial officer, will participate in a virtual fireside

INDIANAPOLIS , Nov. 12, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE:LLY) will participate in the Bernstein Operational Decisions Conference on Monday, November 16, 2020 . Andrew Adams , Ph.D., vice president of new therapeutic modalities and scientific leader for Lilly 's anti-COVID-19

Webcast will not include results from any Phase 3 clinical trials INDIANAPOLIS , Nov. 11, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will conduct a webcast on Friday, November 20, 2020 to provide an overview of the tirzepatide Phase 3 type 2 diabetes clinical trial program in

- Revenue in the third quarter of 2020 increased 5 percent driven by volume growth of 9 percent, while on a year-to-date basis revenue increased 6 percent driven by volume growth of 12 percent.   - Key growth products launched since 2014, consisting of Taltz, Trulicity, Verzenio, Jardiance,